Cargando…

Programmed Cell Death-Ligand-1 expression in Bladder Schistosomal Squamous Cell Carcinoma – There’s room for Immune Checkpoint Blockage?

Schistosoma haematobium, the causative agent of urogenital schistosomiasis, is a carcinogen type 1 since 1994. It is strongly associated with bladder squamous-cell carcinoma in endemic regions, where it accounts for 53-69% of bladder-carcinoma cases. This histological subtype is associated with chro...

Descripción completa

Detalles Bibliográficos
Autor principal:	Madureira, Ana C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486959/ https://www.ncbi.nlm.nih.gov/pubmed/36148227 http://dx.doi.org/10.3389/fimmu.2022.955000

Ejemplares similares

Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition
por: Hakroush, Samy, et al.
Publicado: (2021)

There’s been a Flaw in Our Thinking
por: Anderson, Clark L.
Publicado: (2014)

Immune Evasion Strategies of Schistosomes
por: Hambrook, Jacob R., et al.
Publicado: (2021)

Commentary: “There’s been a Flaw in Our Thinking”
por: Ward, E. Sally, et al.
Publicado: (2015)

Innovations and Advances in Schistosome Stem Cell Research
por: You, Hong, et al.
Publicado: (2021)

Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2017)

There’s education, and then there’s education in medicine
por: ROYAL, KENNETH D., et al.
Publicado: (2016)

Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological Disorders
por: Mu, Yi, et al.
Publicado: (2021)

Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
por: Wang, Baoshan, et al.
Publicado: (2023)

Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors
por: Abdulamir, Ahmed S, et al.
Publicado: (2009)

Schistosomes in the Lung: Immunobiology and Opportunity
por: Houlder, Emma L., et al.
Publicado: (2021)

CD28 Superagonist Shock and Blockage of Motogenic T Cell Cascade
por: Sundqvist, Karl-Gösta
Publicado: (2021)

Prognostic value of programmed cell death ligand-1 expression in patients with bladder urothelial carcinoma undergoing radical cystectomy: A meta-analysis
por: Zhang, Jindong, et al.
Publicado: (2022)

Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells
por: Gibbons Johnson, Rachel M., et al.
Publicado: (2017)

Immunomodulation and Immune Escape Strategies of Gastrointestinal Helminths and Schistosomes
por: Wiedemann, Marie, et al.
Publicado: (2020)

Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis
por: Xu, Yimin, et al.
Publicado: (2021)

Bioengineering and computational analysis of programmed cell death ligand-1 monoclonal antibody
por: Kalim, Muhammad, et al.
Publicado: (2022)

Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of Cancer: An Overview of Systematic Reviews
por: Ou, Shun-Long, et al.
Publicado: (2022)

Soluble monomeric human programmed cell death-ligand 1 inhibits the functions of activated T cells
por: Liang, Zhaoduan, et al.
Publicado: (2023)

Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?
por: Fonseca, Cristina Toscano, et al.
Publicado: (2015)

Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses
por: Costain, Alice H., et al.
Publicado: (2018)

There’s an App for That!
por: Vogel, Wendy H.
Publicado: (2014)

Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1
por: Tai, Yu-Tzu, et al.
Publicado: (2018)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Causal relationships between gut microbiota and programmed cell death protein 1/programmed cell death-ligand 1: A bidirectional Mendelian randomization study
por: Huang, Yu-Feng, et al.
Publicado: (2023)

Cbl-b Deficiency Mediates Resistance to Programmed Death-Ligand 1/Programmed Death-1 Regulation
por: Fujiwara, Mai, et al.
Publicado: (2017)

Corrigendum: Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses
por: Costain, Alice H., et al.
Publicado: (2019)

Measuring stem cell dynamics in the human colon – where there’s a wiggle, there’s a way†
por: Leedham, Simon J
Publicado: (2014)

Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
por: Shen, Xiangfeng, et al.
Publicado: (2019)

Programmed Cell Death Tunes Tumor Immunity
por: Liu, Jing, et al.
Publicado: (2022)

Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus
por: Park, Min-Jung, et al.
Publicado: (2021)

Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression
por: Lundy, Steven K., et al.
Publicado: (2013)

Behind Enemy Lines: Immunomodulatory Armamentarium of the Schistosome Parasite
por: Angeles, Jose Ma. M., et al.
Publicado: (2020)

Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival
por: Yu, Yang, et al.
Publicado: (2022)

Interplay between programmed death-ligand 1 and non-coding RNAs
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4(+) T Effector and Regulatory T Cells in Cutaneous Leishmaniasis
por: de Freitas e Silva, Rafael, et al.
Publicado: (2020)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis
por: Xian, Feng, et al.
Publicado: (2023)

Editorial: Progress of programmed cell death in antitumor immunity
por: Yan, Fangfang, et al.
Publicado: (2023)

The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition
por: van Dorp, Jeroen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_53a6pfagt8oc8fc925lv9hu4la